Oklo Stock Just Got a Major Win. 2026 Could Still Be Its Breakout Year.

Oklo (OKLO) just got a major green light. The U.S. Department of Energy (DOE) recently approved the Documented Safety Analysis for its Groves Isotope Test Reactor in Texas. That's a huge step forward for the company.

The DOE approval confirms the reactor's hazard evaluations, operating requirements, and safety controls. Groves will now move into the final pre-startup review. "The remaining steps are DOE's readiness review and startup approval," Oklo noted in the announcement. Once approved, Oklo will be able to receive nuclear fuel and work toward first criticality. The company is targeting first criticality for July 2026.

More News from Barchart

• Sentiment Could Be Turning Sour on Nvidia. Here's Where 1 Analyst Thinks NVDA Stock Is Headed Next.

• Dear Netflix Stock Fans, Mark Your Calendars for July 16

• Google Just Launched 2 New AI Models. What That Means for GOOGL Stock.

• Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now!

This is the kind of news that can change everything for a small nuclear company. But here's the thing: The real catalyst will be when Groves actually reaches criticality. That will be the moment of truth. That will be when the company goes from concept to reality.

Oklo Has Been on a Wild Ride

Oklo has been a volatile stock. That's typical for a company in the advanced nuclear space. OKLO stock currently trades near $52 per share. Its 52-week range is $44.80 to $193.84, so we're talking about massive swings.

The stock is down 28% year-to-date (YTD), but that doesn't tell the full story. Shares had a huge run-up in 2025 before pulling back. The DOE approval news has breathed new life into OKLO stock, with shares up almost 4% for the past five days.

OKLO stock's movement has been driven by regulatory milestones. Every approval brings the company closer to commercial reality, and the recent DOE approval is the biggest milestone yet. It validates the company's technology and safety approach. That's huge for investor confidence.

But let's be real. Advanced nuclear is a tough business. It takes years to get projects approved. Costs are high, and the technology is unproven at scale. That's why shares of Oklo have been volatile. Investors are betting on potential, but potential doesn't always translate into profits.

Oklo reported a first-quarter loss that matched analyst projections, while providing updates on construction work at its Groves facility. The nuclear technology company posted a loss of $0.19 per share for the quarter ended March 2026.